Population pharmacokinetics of piperacillin/tazobactam in neonates and young infants

European Journal of Clinical Pharmacology

Volumn 69, Issue 6, 2013, Pages 1223-1233

  Li, Zhiping ^a   Chen, Yewei ^a   Li, Qin ^a   Cao, Di ^a   Shi, Wenjing ^a   Cao, Yun ^a   Wu, Dan ^a   Zhu, Yiqing ^a   Wang, Yi ^a   Chen, Chao ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Neonate; Piperacillin tazobactam; Population pharmacokinetics; t > MIC

Indexed keywords

BANGDA; PIPERACILLIN PLUS TAZOBACTAM; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL INFECTION; BODY WEIGHT; BOOTSTRAPPING; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG MECHANISM; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; MINIMUM INHIBITORY CONCENTRATION; NEWBORN; NEWBORN INTENSIVE CARE; PRIORITY JOURNAL; STEADY STATE; TANDEM MASS SPECTROMETRY;

AGE FACTORS; ANTI-BACTERIAL AGENTS; BODY WEIGHT; CHINA; COMPUTER SIMULATION; DRUG DOSAGE CALCULATIONS; DRUG MONITORING; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; INTENSIVE CARE UNITS, NEONATAL; MALE; MODELS, BIOLOGICAL; NONLINEAR DYNAMICS; PENICILLANIC ACID; PIPERACILLIN;

EID: 84878019132     PISSN: 00316970     EISSN: 14321041     Source Type: Journal    
DOI: 10.1007/s00228-012-1413-4     Document Type: Article

References (27)

1. Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, et al. (2007) Infectious diseases society of America/American thoracic society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 44(Suppl 2):S27-S72
2. Mermel LA, Allon M, Bouza E, Craven DE, Flynn P, et al. (2009) Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the infectious diseases society of America. Clin Infect Dis 49:1-45
3. Stevens DL, Bisno AL, Chambers HF, Everett ED, Dellinger P, et al. (2005) Practice guidelines for the diagnosis and management of skin and soft-tissue infections. Clin Infect Dis 41:1373-1406
4. Solomkin JS, Mazuski JE, Bradley JS, Rodvold KA, Goldstein EJ, et al. (2010) Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the surgical infection society and the infectious diseases society of America. Surg Infect (Larchmt) 11:79-109
5. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, et al. (2008) Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 36:296-327
6. Federal Drug Administration (2007) Zosyn® (Piperacillin and Tazobactam for Injection). Available at: http://www.accessdata.fda.gov/ drugsatfda-docs/label/2008/050684s051s052lbl.pdf. Accessed Feb 2007
7. Tornøe CW, Tworzyanski JJ, Imoisili MA, Alexander JJ, Korth-Bradley JM, et al. (2007) Optimising piperacillin/tazobactam dosing in paediatrics. Int J Antimicrob Agents 30:320-324
8. Sörgel F, Kinzig M (1993) The chemistry, pharmacokinetics and tissue distribution of piperacillin/tazobactam. J Antimicrob Chemother 31[Suppl A]:39-60
9. Craig WA (1998) Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men. Clin Infect Dis 26:1-10
10. Lodise TP, Lomaestro BM, Drusano GL; Society of Infectious Diseases Pharmacists (2006) Application of antimicrobial pharmacodynamic concepts into clinical practice: focus on beta-lactam antibiotics: insights from the society of infectious diseases pharmacists. Pharmacotherapy 26:1320-1332
11. Frei CR, Wiederhold NP, Burgess DS (2008) Antimicrobial breakpoints for gram-negative aerobic bacteria based on pharmacokinetic-pharmacodynamic models with Monte Carlo simulation. J Antimicrob Chemother 61:621-628
12. Farrell DJ, Turnidge JD, Bell J, Sader HS, Jones RN (2010) The in vitro evaluation of tigecycline tested against pathogens isolated in eight countries in the Asia-Western Pacific region (2008). J Infect 60:440-451
13. Garrison MW, Mutters R, Dowzicky MJ (2009) In vitro activity of tigecycline and comparator agents against a global collection of Gram-negative and Gram-positive organisms: tigecycline evaluation and surveillance trial 2004 to 2007. Diagn Microbiol Infect Dis 65:288-299
14. Bartelink IH, Rademaker CM, Schobben AF, van den Anker JN (2006) Guidelines on paediatric dosing on the basis of developmental physiology and pharmacokinetic considerations. Clin Pharmacokinet 45:1077-1097
15. McIntyre J, Choonara I (2004) Drug toxicity in the neonate. Biol Neonate 86:218-221
16. Victor S, Helen D, Mark T (2011) Plasma aminotransferase concentrations in preterm infants. Arch Dis Child Fetal Neonatal Ed 96:F144-F145
17. Thayyil S, Sheik S, Kempley ST, Sinha A (2008) A gestation- and postnatal age-based reference chart for assessing renal function in extremely premature infants. J Perinatol 28:226-229
18. van den Anker JN, de Groot R, Broerse HM, Sauer PJ, van der Heijden BJ, et al. (1995) Assessment of glomerular filtration rate in preterm infants by serum creatinine: comparison with inulin clearance. Pediatrics 96:1156-1158
19. Chantler C (1973) The measurement of renal function in children: a review. Guy's Hosp Rep 122:25-41
20. Haycock GB, Schwartz GJ, Wisotsky DH (1978) Geometric method for measuring body surface area: a height-weight formula validated in infants, children, and adults. J Pediatr 93:62-66
21. Schwartz GJ, Feld LG, Langford DJ (1984) A simple estimate of glomerular filtration rate in full-term infants during the first year of life. J Pediatr 104:849-854
22. Li Z, Li Q, Wang Y, Cao D, Chen C (2012) Determination of free and total Piperacillin-Tazobactam in Plasma by HPLC-MS-MS: an adapted method for neonates. Chromatographia 75:533-539
23. Reed MD, Goldfarb J, Yamashita TS, Lemon E, Blumer JL (1994) Single-dose pharmacokinetics of piperacillin and tazobactam in infants and children. Antimicrob Agents Chemother 38:2817-2826
24. Rajagopalan P, Gastonguay MR (2003) Population pharmacokinetics of ciprofloxacin in pediatric patients. J Clin Pharmacol 43:698-710
25. Zuppa AF, Nicolson SC, Barrett JS, Gastonguay MR (2011) Population pharmacokinetics of pentobarbital in neonates, infants, and children after open heart surgery. J Pediatr 159:414-419
26. Agutter PS, Wheatley DN (2004) Metabolic scaling: consensus or controversy? Theor Biol Med Model 1:13
27. Hu TM, Hayton WL (2001) Allometric scaling of xenobiotic clearance: uncertainty versus universality. AAPS PharmSci 3:E29